Generic Medicine OKd by Europe for Thrombocytopenia With HCV - Medscape

Generic Medicine OKd by Europe for Thrombocytopenia With HCV  Medscape

Novartis' Revolade gets expanded coverage for immune thrombocytopenia patients - koreabiomed.com

Novartis' Revolade gets expanded coverage for immune thrombocytopenia patients  koreabiomed.com

Long-term safety data for Revolade in adults with chronic ITP - European Pharmaceutical Review

Long-term safety data for Revolade in adults with chronic ITP  European Pharmaceutical Review

Interim injunction to Novartis against Natco’s use of Revolade patent - The Pharma Letter

Interim injunction to Novartis against Natco’s use of Revolade patent  The Pharma Letter

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia - The New England Journal of Med...

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia  The New England Journal of Medicine

NICE thumbs-up for Revolade - Pharmafile

NICE thumbs-up for Revolade  Pharmafile

Novartis bags EU approvals for three ex-GSK drugs - PMLiVE

Novartis bags EU approvals for three ex-GSK drugs  PMLiVE

New hope for ITP patients dashed by high drug cost - CBC

New hope for ITP patients dashed by high drug cost  CBC

Revolade shows long-term disease control for immune thrombocytopenia - European Pharmaceutical Re...

Revolade shows long-term disease control for immune thrombocytopenia  European Pharmaceutical Review

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results - finchannel

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results  finchannel

Novartis hikes annual earnings guidance as key drugs boost Q3 sales - FirstWord

Novartis hikes annual earnings guidance as key drugs boost Q3 sales  FirstWord

Novartis recalls liquid version of anemia drug Promacta over risk of contamination from peanut fl...

Novartis recalls liquid version of anemia drug Promacta over risk of contamination from peanut flour  Fierce Pharma

Novartis Korea gets additional indication for Revolade - koreabiomed.com

Novartis Korea gets additional indication for Revolade  koreabiomed.com

Cancerous Battle: Novartis and NATCO clash over Eltrombopag - BananaIP

Cancerous Battle: Novartis and NATCO clash over Eltrombopag  BananaIP

GSK guilty of off-label promotion - Pharmafile

GSK guilty of off-label promotion  Pharmafile

Promacta Side Effects Can Lead To Fatal Liver Injuries, Health Canada Warns - AboutLawsuits.com

Promacta Side Effects Can Lead To Fatal Liver Injuries, Health Canada Warns  AboutLawsuits.com

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia - The New England J...

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia  The New England Journal of Medicine

Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia - koreabiomed.com

Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia  koreabiomed.com

GSK’s Promacta extends US licence - Pharmafile

GSK’s Promacta extends US licence  Pharmafile

Novartis’ Revolade proved effective for seniors - koreabiomed.com

Novartis’ Revolade proved effective for seniors  koreabiomed.com

FDA deems GSK anaemia drug a ‘breakthrough’ - PMLiVE

FDA deems GSK anaemia drug a ‘breakthrough’  PMLiVE

Drug Patents and their Evergreening Conundrum - Bar and Bench

Drug Patents and their Evergreening Conundrum  Bar and Bench

Fake cancer drugs sale racket busted in Delhi - The New Indian Express

Fake cancer drugs sale racket busted in Delhi  The New Indian Express